ArticleNPJ Parkinson's disease2025

Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson's disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation.

Chunyan Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.